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Abstract—Using an in vitro system for stimulating human peripheral blood
mononuclear cells (PBMC) with immobilized Ig, patterns of cytokine production as a
function of different Ig classes and subclasses were elucidated. Wells were coated with
IgA, IgGl, IgG2, IgG3 or IgG4. Equivalent protein content on surfaces of wells was
demonstrated by a human kappa chain ELISA. Isolated human PBMC were added
to Ig-coated wells and incubated for 24 hrs before supernatants were assayed for
cytokines. The IgG subclasses showed differences in cytokine production stimulated
from PBMC, with the relative stimulation for TNFa being IgG2 > IgG3 > IgGl >
IgG4 and for IL-6 production, IgG2 > IgG3 > IgGl = IgG4. In contrast, the relative
stimulation for IL-8 was IgGl = IgG2 = IgG3 = IgG4. IgA caused less production of
TNFa when compared to IgG2, but similar levels of IL-8. Such differences may have
important implications in the pathogenesis of immune complex mediated diseases.
INTRODUCTION
Since the discovery of the IgG subclasses, much has been learned about the
structure and biochemistry of these molcules (1-3), whereas much less is known
about their biological function. The subclasses are similar in molecular weight
but differ in their amino acid sequences and functional activities. For exam-
ple, IgGl and IgG3 are superior to IgG2 and IgG4 for activation of comple-
ment. IgGl and IgG3 are produced predominately in response to protein anti-
gens, while IgG2 is produced chiefly in response to carbohydrate antigens (4).
Some clinical correlations have been found, such as susceptibility to encapsu-
lated bacteria (such as H. influenza and Streptococcus pneumoniae) in individuals
with low serum levels of IgG2 (4-6), the association of IgG4 production with
the synthesis of IgE and allergic disorders (4, 7, 8), and correlations between
disease onset and deposition of subclasses of Igs in glomerulonephritis (4, 6),
inflammatory bowel diseases (9, 10) and systemic lupus erythematosus (11). The
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pathogenic mechanisms underlying these associations are still largely unknown.
Since cytokines mediate many inflammatory responses, their production may
be a key step for induction of disease following Ig deposition in tissues. For
instance, patients with IgA-associated nephropathy, alcoholic liver cirrhosis or
acquired immune deficiency syndrome show increased serum levels of IL-l,
TNFa and IL-6 (12). In this report, we have assessed the relative in vitro ability
of IgG subclasses and IgA to induce cytokine production from human peripheral
blood mononuclear cells (PBMC). The data show some strikingly different pat-
terns of cytokine responses as a function of the class or subclass of Ig employed
and the cytokine under analysis.
MATERIALS AND METHODS
Cell Isolation. PBMC were isolated from the venous blood of healthy volunteers by separa-
toin over Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden) followed by two washes with 0.9%
sodium chloride (Abbott Laboratories, North Chicago, Illinois). Cells were resuspended in Dul-
becco's Modified Eagle Medium (Gibco BRL, Gaithersburg, Maryland) containing 10% fetal bovine
serum, 1% L-glutamine, 1% antibiotic/antimycotic and 1% non-essential amino acids (DMEM 10%).
Cells were used at a concentration of 2 x 106 per ml unless otherwise noted. PBMC were used rather
than purified monocytes because of the difficulty of obtaining unstimulated pure cells and the phy-
siological relevance of a mixed cell population.
Reagents. Human myeloma IgG subclasses (all kappa light chain) purified from plasma were
purchased from Sigma (St. Louis, Missouri). Lipopolysaccharide from Escherichia Coli serotype
0111:84 and low endotoxin bovine serum albumin (BSA) were also purchased from Sigma. Purified
human serum IgA was purchased from Organon Teknika-Cappel (Durham, North Carolina).
Coaling of Plates for Cell Stimulation or Kappa Chain ELISA. 96-well Immulon plates
(Dynatech Inc., Chantilly, Virginia) were coated overnight at 4°C with indicated amounts of human
IgG subclasses or BSA. All antibodies were spun for five min at 14,000 rpm before use to remove
any nonspecific aggregates. Dilutions were made in sterile phosphate buffered saline (PBS) and 50
/xl plated per well. IN experiments comparing subclasses, equivalent binding was determined using
an ELISA to detect human kappa light chain. Thus, plates were coated in duplicate, one for cell
stimulation and one for the human kappa chain ELISA to compare immunoglobulin subclass bind-
ing.
Human Kappa Light Chain ELISA. Antibody-coated plates were analyzed with an ELISA
to detect the human kappa light chain. Plates were washed five times in 250 ^1 of PBS before a
combination blocking/primary antibody step was performed. In that step, biotinylated anti-human
kappa chain antibody (Sigma) was diluted 1:2 x 104 in a 5% solution of nonfat dry milk and 200
H\ added per well. The plate was rocked for 45 min at room temperature before washing as above.
100 fil per well of a 1:3000 dilution of strep-avidin conjugated to horseradish peroxidase (Zymed
Laboratories Inc., S. San Francisco, California) was then added and incubated for 30 min. Plates were
washed five times and 200 n\ per well of an o-phenylenediamine dihydrochloride (OPD) substrate
(Sigma) was added. The reaction was stopped after 3-5 min by adding 50 /d per well of 3M Ha 804.
Plates were read at 490 nm on an automated plate reader (Biotek Instruments, Winooski, Vermont).
Mean absorbances of triplicate wells were used to compare binding.
Cell Stimulation. IgG, IgA, or BSA-coated plates were incubated with sterile PBS, in parallel
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with plates undergoing the kappa chain ELISA, before addition of cells. Briefly, plates were washed
with 250 ^I/well of PBS five times and then rocked at room temperature with 200 /xl/well of PBS
for 45 min. Plates were then washed and rocked at room temperature with 100 /xl/well of PBS for
30 min. Plates were washed once again before 200 ^I/well of cells at 2 x 106/ml were added.
Incubation was at 37°C in a humidified, 5% CC>2 incubator for 24 hr unless otherwise indicated.
After incubation, supernatants were harvested in 1.5 ml tubes, spun for 10 min at 14,000 rpm to
pellet any contaminating cells and the supernatants placed in fresh tubes until cytokine analysis,
typically the same day. Otherwise, supernatants were frozen at -20°C until analysis.
Proteinase K Digestion. A 20 ng/ml solution of proteinase K (Promega, Madison, Wiscon-
sin) in Hank's Balanced Salt Solution (HBSS) was used to dilute IgG subclasses and IgA to 0.5
mg/ml and LPS to 0.1 mg/ml. Control samples were diluted in HBSS alone and all treatments were
incubated overnight at 37°C. The following day samples were kept on ice and the extent of digestion
was analyzed by SDS-PAGE followed by Coomassie staining. Plates were then coated with 100 /*!
(50 jig) of each digested or intact antibody, BSA or 200 fil (20 ^g) of enzyme-treated or control
LPS. Cell stimulation was then carried out as described.
Fc Receptor Blocking. After isolation of PBMC, cells were suspended to 10 x 106 cells per
ml in DMEM 10%. Cells were aliquotted for pretreatment with sterile PBS, mouse Fab fragments
(Accurate, Westbury, New York), the mouse monoclonal 32.2 Ffab'h against Fc7RI or the mouse
monoclonal IV.3 Fab against Fc7RcII (Medarex, Annandale, New Jersey). All Fab fragments were
centrifuged at 14,000 rpm for 5 min to remove aggregates, then used at a concentration of 100
/ig/ml. Cells were pretreated for 30 min on ice, then diluted to 2 x 106 per ml in DMEM 10%,
spun for 10 min at 1000 rpm to wash off unbound antibody and resuspended at 2 x 10* per ml.
200 /il/well of treated cells were then added to an antibody-coated plate, incubated for 4 hr, and
supernatants harvested as described under "Cell Stimulation."
LPS Assessment. LPS contamination of the commercial human IgG subclasses and IgA was
assessed using the Limulus Amebocyte Lysate Assay (BioWhittaker, Inc., Walkersville, Maryland).
LPS levels were typically < 1 ng/ml, those above 1 ng/ml were tested side-by-side with equivalent
amounts of LPS. TNFa levels resulting from LPS equivalent to the amount of Ig contamination
were one-tenth that of the Ig stimulation.
Cytokine Quantitalion. TNFa protein was assessed using a sandwich ELISA as described
(13). The minimum level of detection was 1 ng/ml. IL-8 protein was quantitated using a modified
sandwich ELISA (14) and IL-6 was quantitated using a B9 bioassay (15). Measurement of MCP-1
was performed by ELISA as previously described (16).
Statistics. Statistical analysis was performed using SigmaStat (Jandel Corp., Sausalito, Cal-
ifornia). Data satisfying the requirements for normality were analyzed using a one way analysis
of variance (ANOVA) followed by the Student-Newman-Keuls method for pairwise comparisons.
Data failing the normality test were analyzed using a Kruskal-Wallis one way ANOVA on ranks
followed by the Student-Newman-Keuls method for pairwise comparisons. Statistical significance
was recognized as p < 0.05.
RESULTS
Enzymatic Degradation of IgG Subclasses and Abrogation of TNFot Pro-
duction. Preliminary data suggested that several IgG subclasses were capable
of stimulating TNFa production in PBMC (Figure 1). In these experiments, the
rank order of PBMC stimulation was: IgG2 > IgG3 > IgGl » IgG4. To deter-
504 Foreback et al.
Fig. 1. Effect of proteinase K digestion on IgG subclass stimulation of TNFor. IgG subclasses were
incubated overnight with proteinase K or buffer, then assessed for digestion by SDS-PAGE. 50 ng
of digested or intact subclasses were then used to coat a 96-well plate for cell stimulation.
mine whether the ability of IgG subclasses to stimulate PBMC required intact
Ig or might be due to LPS contamination, the subclasses were digested with
the proteolytic enzyme proteinase K and then incubated with microtiter wells
prior to addition of PBMC. This treatment caused extensive degradation of IgG
proteins into low molecular weight fragments as determined by gel electrophore-
sis (data not shown). After digestion, the ability of each subclass to stimulate
TNFa production was abolished (Figure 1), implying that contaminating LPS
was not responsible for the observed findings. As a further control, purified LPS
was treated with proteinase K. Figure 2 shows that, as would be predicted, LPS
treated in this manner was still an effective stimulus for induction of TNFa pro-
duction by PBMC. Experiments performed on IgA showed results similar to the
data with IgG subclasses (data not shown).
From the data in Figure 1, IgG2 appeared to be the best stimulus for TNFa
production. However, differences in activities of IgG subclasses might have been
due to differences in amount of protein adhering to surfaces of microtiter wells.
To directly compare the ability of IgG subclasses to stimulate cytokine produc-
tion, 25 ^g of each subclass were coated onto wells. Approximately equivalent
binding of IgG subclasses to plastic surfaces was demonstrated using an anti-
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Fig. 2. Effect of proteinase K treatment on LPS stimulation of TNFa. LPS was incubated overnight
With proteinase K or buffer. Enzyme or buffer-treated LPS, or BSA, was then used to coat a plate
for cell stimulation. In addition, digested LPS or enzyme solution was added to BSA-coated wells
upon addition of cells to the wells. Bar 1 is TNFa stimulation by proteinase K-treated LPS coating
the well. Bar 2 is TNFa stimulation by buffer-treated LPS coating the well. Bar 3 is a BSA-coated
well stimulated by addition of proteinase K-treated LPS with the cells. Bar 4 is a BSA-coated well
treated with only the enzyme solution added to the cells.
human kappa light chain ELISA (Figure 3). Thus, any differences in cytokine
production induced by various IgG subclasses could not be attributed to differ-
ences in protein adherence to plastic surfaces.
Patterns of TNFa, IL-6, and IL-8 Production in Response to IgG Sub-
classes. IgGl, IgG2, IgG3, and IgG4 were evaluated for their ability to stimu-
late expression of TNFa, IL-6, and IL-8. The results are shown in Figure 4. For
TNFa, IgG2 was more stimulatory than IgG4 (16.4 + 4.0 vs 2.7 ± 0.9, p < 0.05),
while in these experiments TNFa production in response to IgGl and IgG3 could
not be statistically discriminated from IgG2-induced production of TNFa. This
result agrees with that shown in Figure 1. Under the same experimental condi-
tions, in which supernatant fluids were analyzed for IL-6, IgG2, and IgG3 were
more stimulatory than IgGl or IgG4 (difference of ranks = 47.5 for IgG2 vs
IgGl, 42.0 for IgG2 vs IgG4, 34.5 for IgG3 vs IgGl, 29.0 for IgG3 vs IgG4;
p < 0.05). In striking contrast, the response of IL-8 was much more robust, with
no distinguishable differences for any of the IgG subclasses tested (Figure 4C).
As will be shown in Figure 6, the pattern of cytokine responses to IgG subclasses
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Fig. 3. Comparison of IgG subclass binding using an ELISA to detect human kappa chain. A 96-
well plate was coated with the IgG subclasses in a manner identical to plates used for cell stimulation
(Figure 4). The coated plate was then subjected to an ELISA to detect human kappa light chain.
Raw absorbances were used to compare binding, as the subclasses used in this study were all kappa
chain. Bars represent the average absorbance of triplicate wells with the SEM.
was consistent across a range of doses of IgG subclasses. The amount of IL-8
produced in response to IgG subclasses was typically 5-20 fold higher than the
levels of TNFa or IL-6 produced. In the same experiments, MCP-1 levels were
assessed but were too low for detection (data not shown).
To assess the time course for cytokine responses of stimulated PBMC, cell
culture supernatant fluids were collected at 4, 8, 12 and 24 hr (Figure 5). In
frame A the TNFa response reached a plateau between 4 and 8 hr except in the
response to IgGl, which peaked at 24 hr. As shown in Figure 5, the rank order
of TNFa responses was consistent with data in Figure 4: IgG2 > IgG3 > IgGl ^
IgG4. In Figure 5, frame B, IL-8 was produced at consistently high levels with
no discriminant differences in responses to various IgG subclasses. Again, no
statistically significant differences between IgG subclasses were found for IL-8
production. These results indicate that the IgG subclasses show consistent dif-
ferences in their ability to stimulate TNFa, whereas the IL-8 response is similar
for all subclasses of IgG.
Cytokine Responses as a Function of Amount of IgG Subclass Employed.
To evaluate the effect of increasing amounts of IgG subclasses to stimulate
cytokine production, subclasses were compared at 0.5, 5, and 25 ug. In Fig-
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Fig. 4, Cytokines produced by PBMC in response to IgG subclasses. Plates were coated overnight
With 25 ng of IgG subclasses, washed, and cells in medium were added. After 24 hr at 37°C, super-
natants were harvested for assessment of cytokine content. Bars represent the mean of four experi-
ments with the SEM. Significance was recognized as p< 0.05.
ure 6, TNFa and IL-6 levels were low to undetectable with 0.5 jtg. At 5 /*g, the
rank order of IgG subclass ability to stimulate TNFa and IL-6 production was
similar to the pattern found with 25 /*g, also shown in Figure 4. For IL-8 pro-
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Fig. S. Time course of TNFa and IL-8 production by human PBMC in response to IgG subclasses.
Plates were coated overnight with 25 ng of IgG subclasses, washed and cells in medium were added.
At various time points, supernatants were havested and frozen for assessment of cytokine content.
Each point represents the average of triplicate wells with the SEM.
duction, any differences between the subclasses at the 0.5 /xg dose were clearly
gone at the 5 /ig and 25 /ug doses, confirming the findings in Figures 4 and 5.
In other experiments, IgG4 when coated at 50, 100, and 200 jig never induced
TNFa production that exceeded 5.5 ng/ml, demonstrating the relative inability
of IgG4 to stimulate TNFo!. Thus, the differential abilities of the IgG subclasses
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Fig. 6. Cytokines produced by PBMC in response to 0.5, 5 or 25 ng of IgG 1, IgG2, IgG3 or IgG4.
Plates were coated overnight, washed and cells in medium added. After 24 hr at 37°C, supernatants
were harvested for assessment of cytokine content. Bars represent the mean of four experiments
with the SEM.
to stimulate TNFa and IL-6 production hold even at the higher doses of IgG
subclasses employed.
TNFa, IL-6, and IL-8 Responses to IgG2 and IgA. To assess the ability of
human serum IgA to stimulate cytokine production, IgA was compared to IgG2
under conditions identical to those shown in Figures 4 and 5. In Figure 7, the
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Fig. 7. Cytokines produced by PBMC in response to BSA, IgA or IgG2. Plates were coated
overnight with 25 /xg of BSA, IgA or IgG2, washed and cells in medium added. After 24 hr at
37°C, supernatants were harvested for assessment of cytokine content. Bars represent the mean of
four experiments with the SEM. p = N.S. indicates values are not statistically different.
cytokines produced in response to IgA or IgG2 were compared to the responses
to BSA-coated wells. Frame A showed that IgG2 was a better stimulus for TNFa
production when compared to IgA. In this case, a statistically significant differ-
ence was achieved between IgG2 and IgA (16.4 ± 4.0 vs 3.8 ± 0.4, respectively,
p < 0.05). With respect to IL-6 and IL-8 production, there were no statistically
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Fig. 8. Time course of cytokine production by human PBMC in response to 25 /tg of IgG2, IgA or
BSA. Plates were coated overnight, washed and cells in medium were added. At various time points,
supernatants were harvested and frozen for assessment of cytokine content. Each point represents
the average of triplicate wells with the SEM.
Significant differences between cytokine responses of PBMC to IgA and IgG2.
When coihpared over a time course (Figure 8), these trends for TNFa: and IL-8
production persisted, with IgG2 consistently being a better stimulus than IgA
for TNFa production. IL-6 production showed no impressive differences with
respect to IgG2 and IgA for the first 8 hr, while at 12 and 24 hrs IgG2 was
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Fig. 9. TNFa production following blockade of PBMC Fc7RII. Cells were pretreated for 30 min
with medium (Bars 1 and 2), 100 fig/ml of a control mouse Fab fragment (Bar 3), or 100 jig/ml of
the anti-Fc7RII IV.3 Fab (Bar 4). After pretreatment, cells were washed and added to wells coated
with 5 jtg of BSA or IgG2. Following a 4 hr incubation, supernatants were harvested and assessed
for TNFa. Bars represent the average of triplicate wells with the SEM. Results represent one of four
experiments.
a superior stimulus for IL-6 production when compared to IgA. In the case of
IL-8, the response to IgA and IgG2 was the same (Figure 8C).
Role of FcyRII in TNFct Response of PBMC to IgG2. To determine if
PBMC stimulation was occurring through an Fc receptor, Fc receptor blocking
studies were performed using immobilized IgG2 as the stimulus and employing
antibodies to human Fc-yRI and FcyRII. In dose-response experiments with a
4 hr cell stimulation, blocking, when found, was maximal at an antibody con-
centration of 100 ^g/ml (data not shown). Anti-FcyRI F(ab')2, which does not
block activation of FcyRI (17), did not have an inhibitory effect on TNFa or
IL-8 production (data not shown). Anti-FcyRII Fab effects on TNFa responses of
PBMC to IgG2 were studied (Figure 9). Anti-FcyRII reduced the TNFa response
of PBMC by approximately 40%. These studies demonstrate that TNFa produc-
tion by PBMC is stimulated by interaction with solid phase immunoglobulin via
FcyRII interaction with PBMC.
DISCUSSION
Little is known about the ability of subclasses of immunoglobulins to stim-
ulate PBMC for cytokine/chemokine production and the relevance of this phe-
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IgGl = IgG2 = lgG3 = IgG4
"The cytokine assayed following a 24 hr stimulation of PBMC by
immobilized IgG subclasses,
*The relative ability of the IgG subclasses (25 ftg) to stimulate
cytokine production from PBMC.
homenon to induction of human disease by Ig deposition. The ability of IgGl,
IgG2, IgG3, IgG4 and IgA to activate PBMC appears to depend upon which
cytokine (or chemokine) is examined (Table 1), implying that cytokine produc-
tion in response to Ig subclasses must be via different signal transduction path-
ways. For TNFa production, dramatic differences in stimulation were apparent,
particularly between IgG2 and IgG4. A similar pattern of stimulation followed
in the case of IL-6, with IgG2 and IgG3 proving to be superior to IgGl and
IgG4. For IL-8 production, however, the pattern was very different. The IgG
subclasses and IgA, which was a relatively weak stimulus for TNFa production
as compared to IgG2, stimulated IL-8 production approximately equally. This
result demonstrates that IgG4 is capable of functioning as a stimulus and that its
inability to stimulate production of TNFa and IL-6 is not the result of an inac-
tive IgG subclass. Since the IgG subclasses employed were obtained as myeloma
proteins, the possibility exists that the properties displayed are not generalizable
to IgG subclasses. However, multiple lots of IgG2 (each from a different donor)
were found to be consistently superior for stimulation of TNFa production. IgG
subclasses purifed from normal human serum vary in their light chain compo-
sition, making comparisons problematical.
The reasons for the disparate responses in TNFa, IL-6, and IL-8 produc-
tion are unclear. The differing responses may be secondary to differences in Fc
receptor interactions or to engagement of different signal transduction systems.
On freshly isolated monocytes, Fc gamma receptor type I (FcyRI) and Fc gamma
receptor type II (Fc-yRII) have been readily demonstrated, while the FcyRIII is
present in only a subpopulation of cells or after induction by TGF-|3 (18, 19).
The relative specificity of FcyRI for IgG isotypes is known to be IgG3 > IgGl
> IgG4 >» IgG2. Studies on Fc-yRII, however, show different binding capac-
ities based on the receptor allotype of the individual (18, 20). Designated HR
(high responder) and LR (low responder), denned by their effectiveness in a T
cell proliferation assay, HR individuals exhibit a pattern of specificity of IgG3 >
IgGl >» IgG2, IgG4, while LR individuals exhibit the specificity IgG3 > IgGl
= IgG2 >» IgG4 (20). In our studies all donors (n = 6) consistently responded
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most vigorously to IgG2 when compared to the other IgG subclasses. It seems
unlikely that all donors had the same FcyRII allotype. Differential interactions of
the subclasses with FcyRI and Fc7RII may lead to differing cytokine responses.
For example, the superior ability of IgG2 to interact with Pc-yEUI, as compared to
IgG4 (18-20), may result in its optimal stimulation of TNFa production via that
receptor. To study the relative contribution of Fc^RI and Fc7RII, we attempted
cross-linking studies using F(ab')2 and Fab fragments against FC7RI and Fc^RH,
respectively, followed by a goat anti-mouse F(ab')2 to cross-link receptors and
stimulate cytokine production. However, these studies failed to elicit cytokine
production. These failures may reflect a technical problem such as inadequate
binding affinity, etc. Therefore, cross-linking studies could not be further pur-
sued. The next approach was direct blocking studies. It appears that stimula-
tion is occurring through Fe7RII, since blocking that receptor negatively affects
TNFa production. The contribution of Fc-yRI is difficult to assess since the antK
FC7RI 32.2 antibody binds distant to the ligand binding site (17) and is, thus,
ineffective at blocking cytokine production. Using a system of anti-Fc receptor
antibodies, it has been demonstrated that IL-8 production can be induced sec-
ondary to FC7RI cross linking in human monocytes (21). The contribution of
Fc7RI and Fc7RII to production of cytokines by human IgG subclasses remains
to be fully elucidated, however.
Another possibility for differing patterns of TNFa, IL-6, and IL-8 produc-
tion could be disparate signal transduction pathways set in motion by individual
IgG subclasses. The intracellular signals that result from Fc receptor stimulation
are only vaguely defined. It is known that the THP-1 cell line and freshly isolated
human monocytes are stimulated via FC7RI and Fc7RII, resulting in increased
calcium movement and phosphorylation of intracellular proteins (22-26). In
THP-1 cells it appears that cross linking of FC7RI or Fc7RII results in a similar
pattern of protein phosphorylation, including phospholipase C (PLC) 7!, PLC72,
Vav, GAP and the protein kinase Syk (24, 26). The association of Syk with
FC7RII or with the gamma chain of the Fc7RI complex may be responsible for
further phosphorylation (24, 27). The complete pathways have yet to be under-
stood. The possibility exists that different signaling pathways are set in motion
by interaction of different IgG subclasses with Fc receptors. Alternatively, pro-
moters for the TNFa and IL-8 genes may have different sensitivity to the sig-
naling messages produced.
One more aspect of stimulation to be considered is the interaction of various
cell types in the PBMC preparation. The production of IL-8 from human mono-
cytes versus PBMC in response to immobilized IgG has been studied (21) and
confirms another study (28) in which increased IL-8 from PBMC was found
as compared to production by purified monocytes. It has been suggested that
two distinct pathways operate for IL-8 stimulation in monocytes. The first path-
way occurs through stimulation of monocyte FC7RI using an immobilized anti-
Cytokine Responses of Human Blood Monocytes Stimulated with Igs 515
PC7RI antibody. The second pathway is triggered by Fc7RIII stimulation of lym-
phocytes, resulting in production of a soluble, monocyte-stimulating factor (21).
Since our PBMC contain both T cells and monocytes, this second pathway may
explain the ability of all IgG subclasses to stimulate IL-8 production. While
the subclasses may differ in their ability to stimulate monocytes directly via
Fc receptors, they may all affect a second, possibly more sensitive, lymphocyte
pathway equally well. These and other questions will need to be answered to
complete our understanding of IgG subclass and Fc receptor interactions.
The clinical applications of our findings remain to be determined. It is
well known that different classes of immunoglobulins demonstrate deposition
in human tissues expressing inflammatory responses (e.g., predominance of IgG
and IgM in vascular and glomerular deposits of patients with systemic lupus
erythematosus, IgA deposits in vessels and glomeruli of patients with Henoch-
Schonlein vasculitis, etc.). Much less is known about IgG subclass deposition,
although there are some interesting correlations. In systemic lupus erythemato-
sus patients, it has been found that the presence of certain subclasses of anti-
bodies correlate with distinct clinical features (11). IgG3 anti-Sm antibodies cor-
relate with joint involvement while IgG4 anti-Ul ribonucleoprotein antibodies
significantly correlate with muscle involvement. In glomerulonephritis, IgG3 is
the most prevalent IgG subclass in each form of the disease (29). In patients
with membranous glomerulonephropathy, IgG4 is the second most abundant sub-
class, a striking finding since IgG4 normally constitutes only approximately 4%
of IgG in the serum. As for the clinical role of cytokines and IgG subclasses,
it has been known for over a decade that children and adults lacking or defi-
cient in IgG2 often suffer from recurrent pyrogenic infections (5, 30). Further, it
has been shown that treatment which increases serum IgG2 (such as following
intravenous immunoglobulin therapy) can significantly decrease the incidence of
bacterial infections (31, 32). The possibility exists that either the opsonin con-
tent of the infused IgG2 or enhanced cytokine production by IgG2 may account
for the protective effects of intravenously infused immunoglobulins. In some
experimental models of infection, TNFa has been shown to be a critical part
of host resistance. Blocking the endogenous TNFa response can lead to wors-
ening of the infection or death of the animal (33-35). These concepts fit well
with the idea of IgG2 as a potent inducer of TNFa and may be a factor in resis-
tance to bacterial infections. While the physiological role of the IgG subclasses
is not currently understood, the fact that cytokine responses of PBMC appear to
depend on the class and subclass of Ig may be predictive of pathophysiological
associations.
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